A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years

NCT01830855 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
3596
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer